SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,422 | +129.2% | 555 | +423.6% | 0.00% | – |
Q2 2023 | $4,984 | +18.8% | 106 | +6.0% | 0.00% | – |
Q1 2023 | $4,196 | +10.0% | 100 | 0.0% | 0.00% | – |
Q4 2022 | $3,814 | -4.6% | 100 | -6.5% | 0.00% | – |
Q3 2022 | $4,000 | -20.0% | 107 | -27.7% | 0.00% | – |
Q2 2022 | $5,000 | -28.6% | 148 | -15.9% | 0.00% | – |
Q4 2021 | $7,000 | -22.2% | 176 | -17.8% | 0.00% | – |
Q3 2021 | $9,000 | +50.0% | 214 | +94.5% | 0.00% | – |
Q2 2021 | $6,000 | -25.0% | 110 | 0.0% | 0.00% | – |
Q1 2021 | $8,000 | -20.0% | 110 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $10,000 | +42.9% | 110 | 0.0% | 0.00% | – |
Q3 2020 | $7,000 | – | 110 | +450.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 20 | -88.3% | 0.00% | – |
Q1 2020 | $4,000 | 0.0% | 171 | +533.3% | 0.00% | – |
Q3 2019 | $4,000 | -20.0% | 27 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | +25.0% | 27 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | +300.0% | 27 | +200.0% | 0.00% | – |
Q3 2018 | $1,000 | -50.0% | 9 | -47.1% | 0.00% | – |
Q2 2018 | $2,000 | -33.3% | 17 | -19.0% | 0.00% | – |
Q1 2018 | $3,000 | – | 21 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
Diametric Capital, LP | 19,393 | $626,000 | 0.46% |